LONDON (Alliance News) - Allergy Therapeutics PLC said that following the recent inspection of its facilities in Worthing by the Medicines and Healthcare Products Regulatory Agency, the firm Wednesday received its Certificate of GMP Compliance for the site. The specialty pharmaceutical firm Read More

DIRECTOR DEALINGS: Allergy Therapeutics Executives Acquire Shares

25th Apr 2014 08:44

LONDON (Alliance News) - Allergy Therapeutics PLC said Friday that Chief Executive Manuel Llobet and Finance Director Ian Postlewaite acquired shares at nil cost under the company's long term share incentive plan on Thursday, as follows: <table class="aj" style="width: 417px; he Read More

Allergy Therapeutics Extends Term Of Convertible Loan

17th Apr 2014 10:44

LONDON (Alliance News) - Allergy Therapeutics PLC said Thursday that it had extended the term of its GBP4.04 million convertible loan with CFR International SpA. The maturity of the loan has been extended to September 30 from April 20, all other terms of the loan are unchanged. Shares Read More

UK BROKER RATINGS: Jefferies Raises REIT Price Targets

1st Apr 2014 09:11

LONDON (Alliance News) - The following UK shares received analyst recommendations Tuesday morning: ---------- FTSE 100 ---------- GOLDMAN RAISES INTL AIRLINES GROUP (IAG) PRICE TARGET TO 430 (420) PENCE - 'NEUTRAL' ---------- BARCLAYS CUTS PRUDEN Read More

UK MIDDAY BRIEFING: Centamin Soars As Production Beats Expectations

24th Mar 2014 13:15

LONDON (Alliance News) - Metals and minerals producer Centamin is leading the FTSE 250 index Monday despite reporting a hit to pretax profit in 2013, due to a large exceptional cost, but a significant increase in revenue and production. Centamin said pretax profit f Read More

1 2 3 4 5 6 789

FTSE 100 Latest

Value8,809.74

Change53.53